Ab Initio Pharma is proud to once again sponsor the NSW Drug Discovery Forum 2025!

Join us on 5 June2025 as we bring together innovators, researchers, and industry leaders to accelerate the path from discovery to patient impact.

We’re excited to present the ABVance Commercialisation Award, recognising excellence in translational science and supporting teams on their journey from bench to business.

Ab Initio’s CDMO and clinical development services help innovators navigate the critical transition from lab to clinic. Come meet our team and explore how we can support your success.

#DrugDiscovery #DDF2025 #PharmaInnovation #ABVance #AbInitioPharma #CDMO #TranslationalResearch #LifeSciences

Next
Next

Explore GMP Excellence and Clinical Innovation with Ab Initio at ARCS 2025